(Q33498036)

27 July 2017

title

Hematologic changes in a patient with heparin-induced thrombocytopenia who underwent cardiopulmonary bypass after ancrod defibrinogenation (English)

1 reference

heparin-induced thrombocytopenia

27 July 2017

1 reference

1 reference

Spiess BD

1

1 reference

27 July 2017

Gernsheimer T

2

1 reference

27 July 2017

Vocelka C

3

1 reference

27 July 2017

Chandler WL

4

1 reference

27 July 2017

Benak A

5

1 reference

27 July 2017

Joy JV

6

1 reference

27 July 2017

Wright I

7

1 reference

27 July 2017

Hofer BO

8

1 reference

27 July 2017

publication date

1 December 1996

1 reference

Journal of Cardiothoracic and Vascular Anesthesia

27 July 2017

published in

1 reference

27 July 2017

volume

10

1 reference

27 July 2017

issue

7

1 reference

27 July 2017

page(s)

918-921

1 reference

Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2896%2980057-7

7 January 2021

Heparinless cardiopulmonary bypass with ancrod

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2896%2980057-7

7 January 2021

Ancrod (Arvin) as an alternative to heparin anticoagulation for cardiopulmonary bypass.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2896%2980057-7

7 January 2021

Ancrod anticoagulation for cardiopulmonary bypass in heparin-induced thrombocytopenia and thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2896%2980057-7

7 January 2021

Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2896%2980057-7

7 January 2021

Regulation of the Acute Release of Tissue‐type Plasminogen Activator from the Endothelium by Coagulation Activation Products

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2896%2980057-7

7 January 2021

Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2896%2980057-7

7 January 2021

Management of cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia using prostaglandin E1 and aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2896%2980057-7

7 January 2021

The proteolytic action of Arvin on human fibrinogen

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2896%2980057-7

7 January 2021

Heparin and antithrombin III levels during cardiopulmonary bypass: correlation with subclinical plasma coagulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2896%2980057-7

7 January 2021

Efficacy of antithrombin III supplementation in animal models of fulminant Escherichia coli endotoxemia or bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2896%2980057-7

7 January 2021

Antithrombin III replacement in animal models of acquired antithrombin III deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2896%2980057-7

7 January 2021

Rapid release and deactivation of plasminogen activators in human endothelial cell cultures in the presence of thrombin and ionophore A23187

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2896%2980057-7

7 January 2021

10.1016/S1053-0770(96)80057-7

Identifiers

DOI

1 reference

27 July 2017

1 reference